|
1
|
Bray F, Laversanne M, Sung H, ME JF,
Siegel RL, Soerjomataram I and DVM AJ: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J. 74:229–263. PubMed/NCBI
|
|
2
|
Mili N, Paschou SA, Goulis DG, Dimopoulos
MA, Lambrinoudaki I and Psaltopoulou T: Obesity, metabolic
syndrome, and cancer: Pathophysiological and therapeutic
associations. Endocrine. 74:478–497. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Henley SJ, Ward E, Scott S, Ma J, Anderson
RN, Firth AU, Thomas CC, Islami F, Weir HK, Lewis DR, et al: Annual
report to the nation on the status of cancer, Part 1: National
cancer statistics. Cancer. 126:2225–2249. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Avgerinos KI, Spyrou N, Mantzoros CS and
Dalamaga M: Obesity and cancer risk: Emerging biological mechanisms
and perspectives. Metabolism. 92:121–135. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Karpel HC, Slomovitz B, Coleman RL and
Pothuri B: Treatment options for molecular subtypes of endometrial
cancer in 2023. Curr Opin Obstet Gynecol. 35:270–278. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Alexa M, Hasenburg A and Battista MJ: The
TCGA molecular classification of endometrial cancer and its
possible impact on adjuvant treatment decisions. Cancers.
13:14782021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vermij L, Smit V, Nout R and Bosse T:
Incorporation of molecular characteristics into endometrial cancer
management. Histopathology. 76:52–63. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Galant N, Krawczyk P, Monist M, Obara A,
Gajek Ł, Grenda A, Nicoś M, Kalinka E and Milanowski J: Molecular
classification of endometrial cancer and its impact on therapy
selection. Int J Mol Sci. 25:58932024. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Brasseur K, Gévry N and Asselin E:
Chemoresistance and targeted therapies in ovarian and endometrial
cancers. Oncotarget. 8:4008–4042. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wilson EM, Eskander RN and Binder PS:
Recent therapeutic advances in gynecologic oncology: A review.
Cancers. 16:7702024. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Žalytė E: Ferroptosis, metabolic rewiring,
and endometrial cancer. Int J Mol Sci. 25:752023. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Al Mamun A, Geng P, Wang S and Shao C:
Role of pyroptosis in endometrial cancer and its therapeutic
regulation. J Inflamm Res. 17:7037–7056. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Devis-Jauregui L, Eritja N, Davis ML,
Matias-Guiu X and Llobet-Navàs D: Autophagy in the physiological
endometrium and cancer. Autophagy. 17:1077–1095. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fukuda T and Wada-Hiraike O: The Two-faced
role of autophagy in endometrial cancer. Front Cell Dev Biol.
10:8394162022. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nuñez-Olvera SI, Gallardo-Rincón D,
Puente-Rivera J, Salinas-Vera YM, Marchat LA, Morales-Villegas R
and López-Camarillo C: Autophagy machinery as a promising
therapeutic target in endometrial cancer. Front Oncol. 9:13262019.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu J, Zhang L, Wu S and Liu Z:
Ferroptosis: Opportunities and challenges in treating endometrial
cancer. Front Mol Biosci. 9:9298322022. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Brand MD: The sites and topology of
mitochondrial superoxide production. Exp Gerontol. 45:466–472.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
West AP, Shadel GS and Ghosh S:
Mitochondria in innate immune responses. Nat Rev Immunol.
11:389–402. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lambeth JD and Neish AS: Nox enzymes and
new thinking on reactive oxygen: A Double-edged sword revisited.
Annu Rev Pathol Mech Dis. 9:119–145. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang Y, Qi H, Liu Y, Duan C, Liu X, Xia T,
Chen D, Piao HL and Liu HX: The double-edged roles of ROS in cancer
prevention and therapy. Theranostics. 11:4839–4857. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Perillo B, Di Donato M, Pezone A, Di Zazzo
E, Giovannelli P, Galasso G, Castoria G and Migliaccio A: ROS in
cancer therapy: the bright side of the moon. Exp Mol Med.
52:192–203. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
van der Pol A, van Gilst WH, Voors AA and
van der Meer P: Treating oxidative stress in heart failure: Past,
present and future. Eur J Heart Fail. 21:425–435. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Senoner T and Dichtl W: Oxidative stress
in cardiovascular diseases: Still a therapeutic target? Nutrients.
11:20902019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rezzani R and Franco C: Liver, oxidative
stress and metabolic syndromes. Nutrients. 13:3012021. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Teleanu DM, Niculescu AG, Lungu II, Radu
CI, Vladâcenco O, Roza E, Costăchescu B, Grumezescu AM and Teleanu
RI: An overview of oxidative stress, neuroinflammation, and
neurodegenerative diseases. Int J Mol Sci. 23:59382022. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huang R, Chen H, Liang J, Li Y, Yang J,
Luo C, Tang Y, Ding Y, Liu X, Yuan Q, et al: Dual role of reactive
oxygen species and their application in cancer therapy. J Cancer.
12:5543–5561. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta
R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS,
et al: Ferroptosis: An Iron-dependent form of Non-apoptotic cell
death. Cell. 149:1060–1072. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tang D, Chen X, Kang R and Kroemer G:
Ferroptosis: Molecular mechanisms and health implications. Cell
Res. 31:107–125. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li J, Cao F, Yin HL, Huang ZJ, Lin ZT, Mao
N, Sun B and Wang G: Ferroptosis: Past, present and future. Cell
Death Dis. 11:882020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xu Y, Shen J and Ran Z: Emerging views of
mitophagy in immunity and autoimmune diseases. Autophagy. 16:3–17.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lu Y, Li Z, Zhang S, Zhang T, Liu Y and
Zhang L: Cellular mitophagy: Mechanism, roles in diseases and small
molecule pharmacological regulation. Theranostics. 13:736–766.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Onishi M, Yamano K, Sato M, Matsuda N and
Okamoto K: Molecular mechanisms and physiological functions of
mitophagy. EMBO J. 40:e1047052021. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Czegle I, Huang C, Soria PG, Purkiss DW,
Shields A and Wappler-Guzzetta EA: The role of genetic mutations in
mitochondrial-driven cancer growth in selected tumors: Breast and
gynecological malignancies. Life. 13:9962023. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Musicco C, Cormio G, Pesce V, Loizzi V,
Cicinelli E, Resta L, Ranieri G and Cormio A: Mitochondrial
dysfunctions in type I endometrial carcinoma: Exploring their role
in oncogenesis and tumor progression. Int J Mol Sci. 19:20762018.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yıldırım E, Türkler C, Görkem Ü, Şimşek
ÖY, Yılmaz E and Aladağ H: The relationship between oxidative
stress markers and endometrial hyperplasia: A case-control study.
Turk J Obstet Gynecol. 18:298–303. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bukato K, Kostrzewa T, Gammazza AM,
Gorska-Ponikowska M and Sawicki S: Endogenous estrogen metabolites
as oxidative stress mediators and endometrial cancer biomarkers.
Cell Commun Signal. 22:2052024. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Gao Y, Sun W, Wang J, Zhao D, Tian H, Qiu
Y, Ji S, Wang S, Fu Q, Zhang F, et al: Oxidative stress induces
ferroptosis in tendon stem cells by regulating mitophagy through
cGAS-STING pathway. Int Immunopharmacol. 138:1126522024. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Granata S, Votrico V, Spadaccino F,
Catalano V, Netti GS, Ranieri E, Stallone G and Zaza G: Oxidative
Stress and Ischemia/reperfusion injury in kidney transplantation:
Focus on ferroptosis, mitophagy and new antioxidants. Antioxidants
(Basel). 11:7692022. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jomova K, Alomar SY, Alwasel SH,
Nepovimova E, Kuca K and Valko M: Several lines of antioxidant
defense against oxidative stress: antioxidant enzymes,
nanomaterials with multiple enzyme-mimicking activities, and
low-molecular-weight antioxidants. Arch Toxicol. 98:1323–1367.
2024. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zorov DB, Juhaszova M and Sollott SJ:
Mitochondrial reactive oxygen species (ROS) and ROS-Induced ROS
Release. Physiol Rev. 94:909–950. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Phaniendra A, Jestadi DB and Periyasamy L:
Free Radicals: Properties, sources, targets, and their implication
in various diseases. Indian J Clin Biochem. 30:11–26. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Canli Ö, Nicolas AM, Gupta J, Finkelmeier
F, Goncharova O, Pesic M, Neumann T, Horst D, Löwer M, Sahin U and
Greten FR: Myeloid Cell-derived reactive oxygen species induce
epithelial mutagenesis. Cancer Cell. 32:869–883.e5. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kumari S, Badana AK G MM, G S and Malla R:
Reactive oxygen species: A key constituent in cancer survival.
Biomark Insights. 13:11772719187553912018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Iskandar K, Foo J, Liew AQX, Zhu H, Raman
D, Hirpara JL, Leong YY, Babak MV, Kirsanova AA and Armand AS: A
novel MTORC2-AKT-ROS axis triggers mitofission and
mitophagy-associated execution of colorectal cancer cells upon
drug-induced activation of mutant KRAS. Autophagy. 20:1418–1441.
2024. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Srinivas US, Tan BWQ, Vellayappan BA and
Jeyasekharan AD: ROS and the DNA damage response in cancer. Redox
Biol. 25:1010842018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Liu B, Chen Y and St Clair DK: ROS and
p53: Versatile partnership. Free Radic Biol Med. 44:1529–1535.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zhang Y, Choksi S, Chen K, Pobezinskaya Y,
Linnoila I and Liu ZG: ROS play a critical role in the
differentiation of alternatively activated macrophages and the
occurrence of Tumor-associated macrophages. Cell Res. 23:898–914.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zhong LM, Liu ZG, Zhou X, Song SH, Weng
GY, Wen Y, Liu FB, Cao DL and Liu YF: Expansion of PMN-myeloid
derived suppressor cells and their clinical relevance in patients
with oral squamous cell carcinoma. Oral Oncol. 95:157–163. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Jiang J, Wang K, Chen Y, Chen H, Nice EC
and Huang C: Redox regulation in tumor cell epithelial-mesenchymal
transition: molecular basis and therapeutic strategy. Signal
Transduct Target Ther. 2:170362017. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Snezhkina AV, Kudryavtseva AV, Kardymon
OL, Savvateeva MV, Melnikova NV, Krasnov GS and Dmitriev AA: ROS
generation and antioxidant defense systems in normal and malignant
cells. Oxid Med Cell Longev. 2019:61758042019. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Dey P, Baddour J, Muller F, Wu CC, Wang H,
Liao WT, Lan Z, Chen A, Gutschner T, Kang Y, et al: Genomic
deletion of malic enzyme 2 confers collateral lethality in
pancreatic cancer. Nature. 542:119–123. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Wang S, Long H, Hou L, Feng B, Ma Z, Wu Y,
Zeng Y, Cai J, Zhang DW and Zhao G: The mitophagy pathway and its
implications in human diseases. Signal Transduct Target Ther.
8:3042023. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Orvedahl A, Sumpter R, Xiao G, Ng A, Zou
Z, Tang Y, Narimatsu M, Gilpin C, Sun Q and Roth M: Image-based
Genome-Wide siRNA screen identifies selective autophagy factors.
Nature. 480:113–117. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Vara-Perez M, Felipe-Abrio B and Agostinis
P: Mitophagy in cancer: A tale of adaptation. Cells. 8:4932019.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Ferro F, Servais S, Besson P, Roger S,
Dumas JF and Brisson L: Autophagy and mitophagy in cancer metabolic
remodelling. Semin Cell Dev Biol. 98:129–138. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Peoples JN, Saraf A, Ghazal N, Pham TT and
Kwong JQ: Mitochondrial dysfunction and oxidative stress in heart
disease. Exp Mol Med. 51:1622019. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Scheibye-Knudsen M, Fang EF, Croteau DL,
Wilson DM and Bohr VA: Protecting the mitochondrial powerhouse.
Trends Cell Biol. 25:158–170. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Wu W, Xu H, Wang Z, Mao Y, Yuan L, Luo W,
Cui Z, Cui T, Wang XL and Shen YH: PINK1-Parkin-Mediated mitophagy
protects mitochondrial integrity and prevents metabolic
stress-induced endothelial injury. PLoS One. 10:e01324992015.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Song C, Pan S, Zhang J, Li N and Geng Q:
Mitophagy: A novel perspective for insighting into cancer and
cancer treatment. Cell Prolif. 55:e133272022. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Chen Z, Liu L, Cheng Q, Li Y, Wu H, Zhang
W, Zhang W, Wang Y, Sehgal SA, Siraj S, et al: Mitochondrial E3
ligase MARCH5 regulates FUNDC1 to fine-tune hypoxic mitophagy. EMBO
Rep. 18:495–509. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Li J, Agarwal E, Bertolini I, Seo JH,
Caino MC, Ghosh JC, Kossenkov AV, Liu Q, Tang HY, Goldman AR, et
al: The mitophagy effector FUNDC1 controls mitochondrial
reprogramming and cellular plasticity in cancer cells. Sci Signal.
13:eaaz82402020. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Poole LP and Macleod KF: Mitophagy in
tumorigenesis and metastasis. Cell Mol Life Sci. 78:3817–3851.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Akabane S, Matsuzaki K, Yamashita S, Arai
K, Okatsu K, Kanki T, Matsuda N and Oka T: Constitutive activation
of PINK1 protein leads to proteasome-mediated and Non-apoptotic
cell death independently of mitochondrial autophagy. J Biol Chem.
291:16162–16174. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Song C, Pan S, Zhang J, Li N and Geng Q:
Mitophagy: A novel perspective for insighting into cancer and
cancer treatment. Cell Prolif. 55:e133272022. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Liu K, Shi Y, Guo XH, Ouyang YB, Wang SS,
Liu DJ, Wang AN, Li N and Chen DX: Phosphorylated AKT inhibits the
apoptosis induced by DRAM-mediated mitophagy in hepatocellular
carcinoma by preventing the translocation of DRAM to mitochondria.
Cell Death Dis. 5:e10782014. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Yin K, Lee J, Liu Z, Kim H, Martin DR, Wu
D, Liu M and Xue X: Mitophagy protein PINK1 suppresses colon tumor
growth by metabolic reprogramming via p53 activation and reducing
acetyl-CoA production. Cell Death Differ. 28:2421–2435. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Chen L, Mao LS, Xue JY, Jian YH, Deng ZW,
Mazhar M, Zou Y, Liu P, Chen MT, Luo G and Liu MN: Myocardial
ischemia-reperfusion injury: The balance mechanism between
mitophagy and NLRP3 inflammasome. Life Sci. 355:1229982024.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Ikeda H, Kawase K, Nishi T, Watanabe T,
Takenaga K, Inozume T, Ishino T, Aki S, Lin J, Kawashima S, et al:
Immune evasion through mitochondrial transfer in the tumour
microenvironment. Nature. 638:225–236. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Wang SF, Tseng LM and Lee HC: Role of
mitochondrial alterations in human cancer progression and cancer
immunity. J Biomed Sci. 30:612023. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Sun R, Zhou X, Wang T, Liu Y, Wei L, Qiu
Z, Qiu C and Jiang J: Novel insights into tumorigenesis and
prognosis of endometrial cancer through systematic investigation
and validation on mitophagy-related signature. Hum Cell.
36:1548–1563. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Zhao MM, Wang B, Huang WX, Zhang L, Peng R
and Wang C: Verteporfin suppressed mitophagy via PINK1/parkin
pathway in endometrial cancer. Am J Cancer Res. 14:1935–1946. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Jiang X, Stockwell BR and Conrad M:
Ferroptosis: Mechanisms, biology, and role in disease. Nat Rev Mol
Cell Biol. 22:266–282. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Zhang C, Liu X, Jin S, Chen Y and Guo R:
Ferroptosis in cancer therapy: A novel approach to reversing drug
resistance. Mol Cancer. 21:472022. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Chen X, Li J, Kang R, Klionsky DJ and Tang
D: Ferroptosis: Machinery and regulation. Autophagy. 17:2054–2081.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Pandrangi SL, Chittineedi P, Chikati R,
Lingareddy JR, Nagoor M and Ponnada SK: Role of dietary iron
revisited: In metabolism, ferroptosis and pathophysiology of
cancer. Am J Cancer Res. 12:974–985. 2022.PubMed/NCBI
|
|
76
|
Gao W, Wang X, Zhou Y, Wang X and Yu Y:
Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor
immunotherapy. Signal Transduct Target Ther. 7:1962022. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Dai E, Chen X, Linkermann A, Jiang X, Kang
R, Kagan VE, Bayir H, Yang WS, Garcia-Saez AJ, Ioannou MS, et al: A
guideline on the molecular ecosystem regulating ferroptosis. Nat
Cell Biol. 26:1447–1547. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Mou Y, Wang J, Wu J, He D, Zhang C, Duan C
and Li B: Ferroptosis, a new form of cell death: opportunities and
challenges in cancer. J Hematol Oncol. 12:342019. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Zhang M, Zhang T, Song C, Qu J, Gu Y, Liu
S, Li H, Xiao W, Kong L, Sun Y and Lv W: Guizhi Fuling Capsule
ameliorates endometrial hyperplasia through promoting
p62-Keap1-NRF2-mediated ferroptosis. J Ethnopharmacol.
274:1140642021. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
López-Janeiro Á, Ruz-Caracuel I,
Ramón-Patino JL, De Los Ríos V, Villalba Esparza M, Berjón A,
Yébenes L, Hernández A, Masetto I, Kadioglu E, et al: Proteomic
analysis of Low-grade, early-stage endometrial carcinoma reveals
new dysregulated pathways associated with cell death and cell
signaling. Cancers (Basel). 13:7942021. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Tang S and Chen L: The recent advancements
of ferroptosis of gynecological cancer. Cancer Cell Int.
24:3512024. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Huang JY and Yu HN: The role of the Nrf2
pathway in inhibiting ferroptosis in kidney disease and its future
prospects. Pathol Res Pract. 272:1560842025. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Doll S, Proneth B, Tyurina YY, Panzilius
E, Kobayashi S, Ingold I, Irmler M, Beckers J, Aichler M, Walch A,
et al: Acsl4 dictates ferroptosis sensitivity by shaping cellular
lipid composition. Nat Chem Biol. 13:91–98. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Rosenblum SL: Inflammation, dysregulated
iron metabolism, and cardiovascular disease. Front Aging.
4:11241782023. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Wei S, Yu Z, Shi R, An L, Zhang Q, Zhang
Q, Zhang T, Zhang J and Wang H: GPX4 suppresses ferroptosis to
promote malignant progression of endometrial carcinoma via
transcriptional activation by ELK1. BMC Cancer. 22:8812022.
View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Hirayama T, Nagata Y, Nishida M, Matsuo M,
Kobayashi S, Yoneda A, Kanetaka K, Udono H and Eguchi S: Metformin
prevents peritoneal dissemination via Immune-suppressive cells in
the tumor microenvironment. Anticancer Res. 39:4699–4709. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Zhao Y, Wang Y, Zhang X, Han S and Yang B:
Metformin-induced RBMS3 expression enhances ferroptosis and
suppresses ovarian cancer progression. Reprod Biol. 25:1009682025.
View Article : Google Scholar : PubMed/NCBI
|
|
88
|
van den Heerik ASVM, Horeweg N, de Boer
SM, Bosse T and Creutzberg CL: Adjuvant therapy for endometrial
cancer in the era of molecular classification: Radiotherapy,
chemoradiation and novel targets for therapy. Int J Gynecol Cancer.
31:594–604. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Liu Q, Zhao Y, Zhou H and Chen C:
Ferroptosis: Challenges and opportunities for nanomaterials in
cancer therapy. Regen Biomater. 10:rbad0042023. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Sotomayor-Flores C, Rivera-Mejías P,
Vásquez-Trincado C, López-Crisosto C, Morales PE, Pennanen C,
Polakovicova I, Aliaga-Tobar V, García L, Roa JC, et al:
Angiotensin-(1–9) prevents cardiomyocyte hypertrophy by controlling
mitochondrial dynamics via miR-129-3p/PKIA pathway. Cell Death
Differ. 27:2586–2604. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Yang WS, SriRamaratnam R, Welsch ME,
Shimada K, Skouta R, Viswanathan VS, Cheah JH, Clemons PA, Shamji
AF, Clish CB, et al: Regulation of ferroptotic cancer cell death by
GPX4. Cell. 156:317–33. 20141 View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Egan DF, Shackelford DB, Mihaylova MM,
Gelino SR, Kohnz RA, Mair W, Vasquez DS, Joshi A, Gwinn DM, Taylor
R, et al: Phosphorylation of ULK1 (hATG1) by AMP-activated protein
kinase connects energy sensing to mitophagy. Science. 331:456–461.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Zhao L, Zhou X, Xie F and Zhang L, Yan H,
Huang J, Zhang C, Zhou F, Chen J and Zhang L: Ferroptosis in cancer
and cancer immunotherapy. Cancer Commun. 42:88–116. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Cormio A, Musicco C, Gasparre G, Cormio G,
Pesce V, Sardanelli AM and Gadaleta MN: Increase in proteins
involved in mitochondrial fission, mitophagy, proteolysis and
antioxidant response in type I endometrial cancer as an adaptive
response to respiratory complex I deficiency. Biochem Biophys Res
Commun. 491:85–90. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Liu C, Li Z, Li B, Liu W, Zhang S, Qiu K
and Zhu W: Relationship between ferroptosis and mitophagy in
cardiac ischemia reperfusion injury: A mini-review. PeerJ.
11:e149522023. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Bi Y, Liu S, Qin X, Abudureyimu M, Wang L,
Zou R, Ajoolabady A, Zhang W, Peng H, Ren J and Zhang Y: FUNDC1
interacts with GPx4 to govern hepatic ferroptosis and fibrotic
injury through a mitophagy-dependent manner. J Adv Res. 55:45–60.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Wilhelm LP, Zapata-Muñoz J, Villarejo-Zori
B, Pellegrin S, Freire CM, Toye AM, Boya P and Ganley IG:
BNIP3L/NIX regulates both mitophagy and pexophagy. EMBO J.
41:e1111152022. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Yamashita SI, Sugiura Y, Matsuoka Y, Maeda
R, Inoue K, Furukawa K, Fukuda T, Chan DC and Kanki T: Mitophagy
mediated by BNIP3 and NIX protects against ferroptosis by
downregulating mitochondrial reactive oxygen species. Cell Death
Differ. 31:651–661. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Yang CH, Almomen A, Wee YS, Jarboe EA,
Peterson CM and Janát-Amsbury MM: An estrogen-induced endometrial
hyperplasia mouse model recapitulating human disease progression
and genetic aberrations. Cancer Med. 4:1039–1050. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Fan R, Wang Y, Wang Y, Wei L and Zheng W:
Mechanism of progestin resistance in endometrial precancer/cancer
through Nrf2-survivin pathway. Am J Transl Res. 9:1483–1491.
2017.PubMed/NCBI
|
|
101
|
Yi J, Zhu J, Wu J, Thompson CB and Jiang
X: Oncogenic activation of PI3K-AKT-mTOR signaling suppresses
ferroptosis via SREBP-mediated lipogenesis. Proc Natl Acad Sci USA.
117:31189–31197. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Álvarez-Garcia V, Tawil Y, Wise HM and
Leslie NR: Mechanisms of PTEN loss in cancer: It's all about
diversity. Semin Cancer Biol. 59:66–79. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Nero C, Ciccarone F, Pietragalla A and
Scambia G: PTEN and gynecological cancers. Cancers. 11:14582019.
View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Wang P, Zhang XP, Liu F and Wang W:
Progressive Deactivation of Hydroxylases Controls Hypoxia-Inducible
Factor-1α-Coordinated Cellular Adaptation to Graded Hypoxia.
Research. 8:06512025. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Wang P, Dai X, Jiang W, Li Y and Wei W:
RBR E3 ubiquitin ligases in tumorigenesis. Semin Cancer Biol.
67:131–144. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Zhang HL, Hu BX, Li ZL, Du T, Shan JL, Ye
ZP, Peng XD, Li X, Huang Y, Zhu XY, et al: PKCβII phosphorylates
ACSL4 to amplify lipid peroxidation to induce ferroptosis. Nature
Cell Biol. 24:88–98. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Jaramillo MC and Zhang DD: The emerging
role of the Nrf2-Keap1 signaling pathway in cancer. Genes Dev.
27:2179–2191. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Yang B, Hu M, Fu Y, Sun D, Zheng W, Liao
H, Zhang Z and Chen X: LASS2 mediates Nrf2-driven progestin
resistance in endometrial cancer. Am J Transl Res. 13:1280–1289.
2021.PubMed/NCBI
|
|
109
|
Read AD, Bentley RET, Archer SL and
Dunham-Snary KJ: Mitochondrial iron-sulfur clusters: Structure,
function, and an emerging role in vascular biology. Redox Biol.
47:1021642021. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Luo J, Zhang X, Liang Z, Zhuang W, Jiang
M, Ma M, Peng S, Huang S, Qiao G and Chen Q: ISCU-p53 axis
orchestrates macrophage polarization to dictate immunotherapy
response in esophageal squamous cell carcinoma. Cell Death Dis.
16:4622025. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Yang H, Yao X, Liu Y, Shen X, Li M and Luo
Z: Ferroptosis Nanomedicine: Clinical Challenges and Opportunities
for Modulating Tumor Metabolic and Immunological Landscape. ACS
Nano. 17:15328–15353. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Glorieux C, Liu S, Trachootham D and Huang
P: Targeting ROS in cancer: Rationale and strategies. Nature
Reviews Drug Discovery. 23:583–606. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
McKee CA, Polino AJ, King MW and Musiek
ES: Circadian clock protein BMAL1 broadly influences autophagy and
endolysosomal function in astrocytes. Proc Natl Acad Sci USA.
120:e22205511202025. View Article : Google Scholar
|
|
114
|
Makovec T: Cisplatin and beyond: Molecular
mechanisms of action and drug resistance development in cancer
chemotherapy. Radiol Oncol. 53:148–1458. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Dasari S and Tchounwou PB: Cisplatin in
cancer therapy: Molecular mechanisms of action. Eur J Pharmacol.
740:364–378. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Mauro-Lizcano M, Sotgia F and Lisanti MP:
Mitophagy and cancer: Role of BNIP3/BNIP3L as energetic drivers of
stemness features, ATP production, proliferation, and cell
migration. Aging (Albany NY). 16:9334–9349. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Li K, Xu K, He Y, Yang Y, Tan M, Mao Y,
Zou Y, Feng Q, Luo Z and Cai K: Oxygen Self-generating nanoreactor
mediated ferroptosis activation and immunotherapy in
Triple-negative breast cancer. ACS Nano. 17:4667–4687. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Xu L, Fang Q, Miao Y, Xu M, Wang Y, Sun L
and Jia X: The role of CCR2 in prognosis of patients with
endometrial cancer and tumor microenvironment remodeling.
Bioengineered. 12:3467–3484. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Nizami ZN, Aburawi HE, Semlali A, Muhammad
K and Iratni R: Oxidative stress inducers in cancer therapy:
Preclinical and clinical evidence. Antioxidants. 12:11592023.
View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Li J, Jia Y Chen, Ding Y Xuan, Bai J, Cao
F and Li F: The crosstalk between ferroptosis and mitochondrial
dynamic regulatory networks. Int J Biol Sci. 19:2756–2771. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
121
|
CD8+ T cells and fatty acids orchestrate
tumor ferroptosis and immunity via ACSL4-PMC [Internet], . [cited
2025 Sept 10]. Available from. https://pmc.ncbi.nlm.nih.gov/articles/PMC9007863/
|
|
122
|
Huo K, Yang Y, Yang T, Zhang W and Shao J:
Identification of drug targets and agents associated with
ferroptosis-related osteoporosis through integrated network
pharmacology and molecular docking technology. Curr Pharm Des.
30:1103–1114. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Hu G, Yuan Z and Wang J: Autophagy
inhibition and ferroptosis activation during atherosclerosis:
Hypoxia-inducible factor 1α inhibitor PX-478 alleviates
atherosclerosis by inducing autophagy and suppressing ferroptosis
in macrophages. Biomed Pharmacother. 161:1143332023. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Bhatt V, Lan T, Wang W, Kong J, Lopes EC,
Wang J, Khayati K, Raju A, Rangel M, Lopez E, et al: Inhibition of
autophagy and MEK promotes ferroptosis in Lkb1-deficient
Kras-driven lung tumors. Cell Death Dis. 14:612023. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Crouigneau R, Li YF, Auxillos J,
Goncalves-Alves E, Marie R, Sandelin A and Pedersen SF: Mimicking
and analyzing the tumor microenvironment. Cell Rep Methods.
4:1008662024. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Early JO, Menon D, Wyse CA,
Cervantes-Silva MP, Zaslona Z, Carroll RG, Palsson-McDermott EM,
Angiari S, Ryan DG, Corcoran SE, et al: Circadian clock protein
BMAL1 regulates IL-1β in macrophages via NRF2. Proc Natl Acad Sci
USA. 115:E8460–E8468. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Wang Z, Ge S, Liao T, Yuan M, Qian W, Chen
Q, Liang W, Cheng X, Zhou Q, Ju Z, et al: Integrative single-cell
metabolomics and phenotypic profiling reveals metabolic
heterogeneity of cellular oxidation and senescence. Nat Commun.
16:27402025. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Doll S, Freitas FP, Shah R, Aldrovandi M,
da Silva MC, Ingold I, Grocin AG, da Silva TNX, Panzilius E, Scheel
CH, et al: FSP1 is a glutathione-independent ferroptosis
suppressor. Nature. 575:693–698. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
129
|
Bersuker K, Hendricks J, Li Z, Magtanong
L, Ford B, Tang PH, Roberts MA, Tong B, Maimone TJ, Zoncu R, et al:
The CoQ oxidoreductase FSP1 acts in parallel to GPX4 to inhibit
ferroptosis. Nature. 575:688–692. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
130
|
Pekovic-Vaughan V, Gibbs J, Yoshitane H,
Yang N, Pathiranage D, Guo B, Sagami A, Taguchi K, Bechtold D,
Loudon A, et al: The circadian clock regulates rhythmic activation
of the NRF2/glutathione-mediated antioxidant defense pathway to
modulate pulmonary fibrosis. Genes Dev. 28:548–560. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Mao C, Liu X, Zhang Y, Lei G, Yan Y, Lee
H, Koppula P, Wu S, Zhuang L, Fang B, et al: DHODH-mediated
ferroptosis defense is a targetable vulnerability in cancer.
Nature. 593:586–590. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Oh M, Jang SY, Lee JY, Kim JW, Jung Y, Kim
J, Seo J, Han TS, Jang E, Son HY, et al: The lipoprotein-associated
phospholipase A2 inhibitor Darapladib sensitises cancer cells to
ferroptosis by remodelling lipid metabolism. Nat Commun.
14:57282023. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Błachnio-Zabielska AU, Sadowska P,
Zdrodowski M, Laudański P and Szamatowicz J and Szamatowicz J: The
Interplay between Oxidative Stress and Sphingolipid Metabolism in
Endometrial Cancer. Int J Mol Sci. 25:102432024. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Hsin IL, Shen HP, Chang HY, Ko JL and Wang
PH: Suppression of PI3K/Akt/mTOR/c-Myc/mtp53 Positive Feedback Loop
Induces Cell Cycle Arrest by Dual PI3K/mTOR Inhibitor PQR309 in
Endometrial Cancer Cell Lines. Cells. 10:29162021. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Ruiz-Mitjana A, Vidal-Sabanés M, Navaridas
R, Perramon-Güell A, Yeramian A, Nicholson-Sabaté N, Egea J,
Encinas M, Matias-Guiu X and Dolcet X: Metformin exhibits
antineoplastic effects on Pten-deficient endometrial cancer by
interfering with TGF-β and p38/ERK MAPK signalling. Biomed
Pharmacother. 168:1158172023. View Article : Google Scholar : PubMed/NCBI
|
